These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 14959697)

  • 1. HIV therapeutics in children and adults and their side effects.
    Laurence J
    AIDS Read; 2004 Jan; 14(1):6-7. PubMed ID: 14959697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which antiretroviral strategy to use in adults?].
    Tonnerre P
    Rev Infirm; 2003 Sep; (93):12-6. PubMed ID: 14593983
    [No Abstract]   [Full Text] [Related]  

  • 3. Patients who want to stop their medications: treatment interruptions in HIV infection.
    Ball SC
    AIDS Read; 2003 Jul; 13(7):317-9, 324, 342. PubMed ID: 12889449
    [No Abstract]   [Full Text] [Related]  

  • 4. Take HAART: medication adherence in the era of highly active antiretroviral therapy.
    Allardice K
    Aust Nurs J; 2002 Apr; 9(9):19-21. PubMed ID: 12017049
    [No Abstract]   [Full Text] [Related]  

  • 5. Optimizing efficacy and tolerability in today's HAART.
    Pozniak A
    AIDS Read; 2003 Sep; ():S4-8. PubMed ID: 14601553
    [No Abstract]   [Full Text] [Related]  

  • 6. Treating HIV infection and AIDS in women.
    Squires KE
    AIDS Read; 2003 May; 13(5):228-34, 239-40. PubMed ID: 12800826
    [No Abstract]   [Full Text] [Related]  

  • 7. Issues in antiretroviral therapy: when to start?
    Boyle BA
    AIDS Read; 2001 Feb; 11(2):66-70. PubMed ID: 11279874
    [No Abstract]   [Full Text] [Related]  

  • 8. Simplifying HIV therapeutics, and the global treatment of AIDS.
    Laurence J
    AIDS Read; 2003 Jan; 13(1):5-6. PubMed ID: 12569889
    [No Abstract]   [Full Text] [Related]  

  • 9. Three types of adherence to HIV antiretroviral therapy and their association with AIDS diagnosis, medication side-effects, beliefs about antiretroviral therapy, and beliefs about HIV disease.
    Schönnesson LN; Williams ML; Ross MW; Diamond PM; Keel B
    Int J STD AIDS; 2007 Jun; 18(6):369-73. PubMed ID: 17609023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience.
    Rajasekaran S; Jeyaseelan L; Vijila S; Gomathi C; Raja K
    AIDS; 2007 Jul; 21 Suppl 4():S47-53. PubMed ID: 17620752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
    Ruiz L; Paredes R; Gómez G; Romeu J; Domingo P; Pérez-Alvarez N; Tambussi G; Llibre JM; Martínez-Picado J; Vidal F; Fumaz CR; Clotet B;
    AIDS; 2007 Jan; 21(2):169-78. PubMed ID: 17197807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
    Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
    HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing adherence to antiretrovirals: strategies and regimens.
    Stone VE
    MedGenMed; 2002 Jul; 4(3):22. PubMed ID: 12466765
    [No Abstract]   [Full Text] [Related]  

  • 14. HIV meds: keeping trouble at bay.
    Daughtry LM; Bankston JB; Deshotels JM
    RN; 2002 Feb; 65(2):31-5; quiz 36. PubMed ID: 15328865
    [No Abstract]   [Full Text] [Related]  

  • 15. Sustained viral suppression and immune recovery in HIV type 1-infected children after 4 years of highly active antiretroviral therapy.
    Fraaij PL; Verweel G; van Rossum AM; van Lochem EG; Schutten M; Weemaes CM; Hartwig NG; Burger DM; de Groot R
    Clin Infect Dis; 2005 Feb; 40(4):604-8. PubMed ID: 15712085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. British HIV Association (BHIVA) guidelines for the treatment of HIV-infected adults with antiretroviral therapy (2005).
    Gazzard B;
    HIV Med; 2005 Jul; 6 Suppl 2():1-61. PubMed ID: 16011536
    [No Abstract]   [Full Text] [Related]  

  • 17. CD4 lymphocyte percentage versus absolute CD4 lymphocyte count in predicting HIV disease progression: an old debate revisited.
    Goicoechea M; Haubrich R
    J Infect Dis; 2005 Sep; 192(6):945-7. PubMed ID: 16107944
    [No Abstract]   [Full Text] [Related]  

  • 18. A programme of symptom management for improving quality of life and drug adherence in AIDS/HIV patients.
    Chiou PY; Kuo BI; Lee MB; Chen YM; Chuang P; Lin LC
    J Adv Nurs; 2006 Jul; 55(2):169-79. PubMed ID: 16866809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-positive youths.
    Am J Nurs; 2001 Jun; 101(6):19. PubMed ID: 11441755
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.